International Stem Cell (OTCMKTS:ISCO – Get Free Report) posted its quarterly earnings results on Thursday. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter, Zacks reports. International Stem Cell Stock Performance ISCO traded down $0.02 on Thursday, hitting $0.31. 2,134 shares of the company were exchanged, compared to its average volume of […]

International Stem Cell (OTCMKTS:ISCO – Get Free Report) and Lantern Pharma (NASDAQ:LTRN – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends. Institutional & Insider Ownership 28.6% of […]

International Stem Cell (OTCMKTS:ISCO – Get Free Report) and Lantern Pharma (NASDAQ:LTRN – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations. Valuation & Earnings This table compares […]